Growing roles for the mTOR pathway

Vezina, 1975, Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle, J Antibiot (Tokyo), 28, 721, 10.7164/antibiotics.28.721

Cafferkey, 1993, Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity, Mol Cell Biol, 13, 6012, 10.1128/MCB.13.10.6012

Kunz, 1993, Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression, Cell, 73, 585, 10.1016/0092-8674(93)90144-F

Sabatini, 1994, RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs, Cell, 78, 35, 10.1016/0092-8674(94)90570-3

Brown, 1994, A mammalian protein targeted by G1-arresting rapamycin-receptor complex, Nature, 369, 756, 10.1038/369756a0

Sabers, 1995, Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells, J Biol Chem, 270, 815, 10.1074/jbc.270.2.815

Kim, 2003, GβL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR, Mol Cell, 11, 895, 10.1016/S1097-2765(03)00114-X

Kim, 2002, mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery, Cell, 110, 163, 10.1016/S0092-8674(02)00808-5

Hara, 2002, Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action, Cell, 110, 177, 10.1016/S0092-8674(02)00833-4

Loewith, 2002, Two TOR complexes, only one of which is rapamycin-sensitive, have distinct roles in cell growth control, Mol Cell, 10, 457, 10.1016/S1097-2765(02)00636-6

Sarbassov, 2004, Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton, Curr Biol, 14, 1296, 10.1016/j.cub.2004.06.054

Jacinto, 2004, Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive, Nat Cell Biol, 6, 1122, 10.1038/ncb1183

Richter, 2005, Regulation of cap-dependent translation by eIF4E inhibitory proteins, Nature, 433, 477, 10.1038/nature03205

Hannan, 2003, mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF, Mol Cell Biol, 23, 8862, 10.1128/MCB.23.23.8862-8877.2003

Peng, 2002, The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation, Mol Cell Biol, 22, 5575, 10.1128/MCB.22.15.5575-5584.2002

Meijer, 2004, Regulation and role of autophagy in mammalian cells, Int J Biochem Cell Biol, 36, 2445, 10.1016/j.biocel.2004.02.002

Martin, 2004, TOR regulates ribosomal protein gene expression via PKA and the Forkhead transcription factor FHL1, Cell, 119, 969, 10.1016/j.cell.2004.11.047

Chung, 1992, Rapamycin–FKBP specifically blocks growth-dependent activation of and signaling by the 70 kD S6 protein kinases, Cell, 69, 1227, 10.1016/0092-8674(92)90643-Q

Kuo, 1992, Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase, Nature, 358, 70, 10.1038/358070a0

Price, 1992, Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase, Science, 257, 973, 10.1126/science.1380182

Burnett, 1998, RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1, Proc Natl Acad Sci USA, 95, 1432, 10.1073/pnas.95.4.1432

Pende, 2004, S6K1−/−/S6K2−/− mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway, Mol Cell Biol, 24, 3112, 10.1128/MCB.24.8.3112-3124.2004

Montagne, 1999, Drosophila S6 kinase: a regulator of cell size, Science, 285, 2126, 10.1126/science.285.5436.2126

Fingar, 2002, Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E, Genes Dev, 16, 1472, 10.1101/gad.995802

Oldham, 2000, Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin, Genes Dev, 14, 2689, 10.1101/gad.845700

Zhang, 2000, Regulation of cellular growth by the Drosophila target of rapamycin dTOR, Genes Dev, 14, 2712, 10.1101/gad.835000

Ohanna, 2005, Atrophy of S6K1−/− skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control, Nat Cell Biol, 7, 286, 10.1038/ncb1231

Bodine, 2001, Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo, Nat Cell Biol, 3, 1014, 10.1038/ncb1101-1014

Rommel, 2001, Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways, Nat Cell Biol, 3, 1009, 10.1038/ncb1101-1009

Park, 2005, MTOR signaling is required for a late-stage fusion process during skeletal myotube maturation, J Biol Chem, 280, 32009, 10.1074/jbc.M506120200

Stolovich, 2002, Transduction of growth or mitogenic signals into translational activation of TOP mRNAs is fully reliant on the phosphatidylinositol 3-kinase-mediated pathway but requires neither S6K1 nor rpS6 phosphorylation, Mol Cell Biol, 22, 8101, 10.1128/MCB.22.23.8101-8113.2002

Wang, 2001, Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase, EMBO J, 20, 4370, 10.1093/emboj/20.16.4370

Raught, 2004, Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases, EMBO J, 23, 1761, 10.1038/sj.emboj.7600193

Richardson, 2004, SKAR is a specific target of S6 kinase 1 in cell growth control, Curr Biol, 14, 1540, 10.1016/j.cub.2004.08.061

Schalm, 2003, TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function, Curr Biol, 13, 797, 10.1016/S0960-9822(03)00329-4

Schalm, 2002, Identification of a conserved motif required for mTOR signaling, Curr Biol, 12, 632, 10.1016/S0960-9822(02)00762-5

Nojima, 2003, The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif, J Biol Chem, 278, 15461, 10.1074/jbc.C200665200

Colombani, 2003, A nutrient sensor mechanism controls Drosophila growth, Cell, 114, 739, 10.1016/S0092-8674(03)00713-X

Ali, 2005, Structure of S6 kinase 1 determines whether raptor–mTOR or rictor–mTOR phosphorylates its hydrophobic motif site, J Biol Chem, 280, 19445, 10.1074/jbc.C500125200

Sarbassov, 2005, Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex, Science, 307, 1098, 10.1126/science.1106148

Lee, 2005, TOR complex 2 integrates cell movement during chemotaxis and signal relay in Dictyostelium, Mol Biol Cell, 10.1091/mbc.E05-04-0342

Birkenkamp, 2003, Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors, Biochem Soc Trans, 31, 292, 10.1042/bst0310292

Zhou, 2001, HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation, Nat Cell Biol, 3, 973, 10.1038/ncb1101-973

Ogawara, 2002, Akt enhances Mdm2-mediated ubiquitination and degradation of p53, J Biol Chem, 277, 21843, 10.1074/jbc.M109745200

Helliwell, 1998, The Rho1 effector Pkc1, but not Bni1, mediates signalling from Tor2 to the actin cytoskeleton, Curr Biol, 8, 1211, 10.1016/S0960-9822(07)00511-8

Hentges, 2001, FRAP/mTOR is required for proliferation and patterning during embryonic development in the mouse, Proc Natl Acad Sci USA, 98, 13796, 10.1073/pnas.241184198

Gangloff, 2004, Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development, Mol Cell Biol, 24, 9508, 10.1128/MCB.24.21.9508-9516.2004

Murakami, 2004, mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells, Mol Cell Biol, 24, 6710, 10.1128/MCB.24.15.6710-6718.2004

Tapon, 2001, The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation, Cell, 105, 345, 10.1016/S0092-8674(01)00332-4

Gao, 2002, Tsc tumour suppressor proteins antagonize amino-acid–TOR signalling, Nat Cell Biol, 4, 699, 10.1038/ncb847

Saucedo, 2003, Rheb promotes cell growth as a component of the insulin/TOR signalling network, Nat Cell Biol, 5, 566, 10.1038/ncb996

Stocker, 2003, Rheb is an essential regulator of S6K in controlling cell growth in Drosophila, Nat Cell Biol, 5, 559, 10.1038/ncb995

Zhang, 2003, Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins, Nat Cell Biol, 5, 578, 10.1038/ncb999

Tee, 2003, Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb, Curr Biol, 13, 1259, 10.1016/S0960-9822(03)00506-2

Garami, 2003, Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2, Mol Cell, 11, 1457, 10.1016/S1097-2765(03)00220-X

Long, 2005, Rheb binds and regulates the mTOR kinase, Curr Biol, 15, 702, 10.1016/j.cub.2005.02.053

Inoki, 2003, TSC2 mediates cellular energy response to control cell growth and survival, Cell, 115, 577, 10.1016/S0092-8674(03)00929-2

Reiling, 2004, The hypoxia-induced paralogs Scylla and Charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila, Genes Dev, 18, 2879, 10.1101/gad.322704

Brugarolas, 2004, Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex, Genes Dev, 18, 2893, 10.1101/gad.1256804

Sofer, 2005, Regulation of mTOR and cell growth in response to energy stress by REDD1, Mol Cell Biol, 25, 5834, 10.1128/MCB.25.14.5834-5845.2005

Schwarzer, 2005, REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase, Oncogene, 24, 1138, 10.1038/sj.onc.1208236

Inoki, 2002, TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling, Nat Cell Biol, 4, 648, 10.1038/ncb839

Potter, 2002, Akt regulates growth by directly phosphorylating Tsc2, Nat Cell Biol, 4, 658, 10.1038/ncb840

Manning, 2002, Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway, Mol Cell, 10, 151, 10.1016/S1097-2765(02)00568-3

Roux, 2004, Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase, Proc Natl Acad Sci USA, 101, 13489, 10.1073/pnas.0405659101

Tee, 2003, Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin, J Biol Chem, 278, 37288, 10.1074/jbc.M303257200

Ma, 2005, Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis, Cell, 121, 179, 10.1016/j.cell.2005.02.031

Hahn-Windgassen, 2005, Akt activates mTOR by regulating cellular ATP and AMPK activity, J Biol Chem, 10.1074/jbc.M502876200

Edinger, 2002, Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake, Mol Biol Cell, 13, 2276, 10.1091/mbc.01-12-0584

Long, 2005, Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency, J Biol Chem, 280, 23433, 10.1074/jbc.C500169200

Takano, 2001, Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin, Mol Cell Biol, 21, 5050, 10.1128/MCB.21.15.5050-5062.2001

Tremblay, 2001, Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells, J Biol Chem, 276, 38052, 10.1074/jbc.M106703200

Haruta, 2000, A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1, Mol Endocrinol, 14, 783, 10.1210/me.14.6.783

Harrington, 2004, The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins, J Cell Biol, 166, 213, 10.1083/jcb.200403069

Carlson, 2004, Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation, Biochem Biophys Res Commun, 316, 533, 10.1016/j.bbrc.2004.02.082

Chiang, 2005, Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase, J Biol Chem, 280, 25485, 10.1074/jbc.M501707200

Holz, 2005, Identification of S6K1 as a novel mTOR-phosphorylating kinase, J Biol Chem, 10.1074/jbc.M504045200

Di Mario, 2004, The impact of sirolimus eluting stents in interventional cardiology, Int J Cardiol, 95, 117, 10.1016/j.ijcard.2003.10.010

Chueh, 2005, Clinical application of sirolimus in renal transplantation: an update, Transpl Int, 18, 261, 10.1111/j.1432-2277.2004.00039.x

Radimerski, 2002, Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling, Genes Dev, 16, 2627, 10.1101/gad.239102

Shaw, 2004, The LKB1 tumor suppressor negatively regulates mTOR signaling, Cancer Cell, 6, 91, 10.1016/j.ccr.2004.06.007

Corradetti, 2004, Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz–Jeghers syndrome, Genes Dev, 18, 1533, 10.1101/gad.1199104

Neshat, 2001, Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR, Proc Natl Acad Sci USA, 98, 10314, 10.1073/pnas.171076798

Podsypanina, 2001, An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/− mice, Proc Natl Acad Sci USA, 98, 10320, 10.1073/pnas.171060098

Ma, 2005, Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression, Genes Dev, 19, 1779, 10.1101/gad.1314405

Manning, 2005, Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2, Genes Dev, 19, 1773, 10.1101/gad.1314605